Literature DB >> 29377280

A fifth subtype of Kaposi's sarcoma, classic Kaposi's sarcoma in men who have sex with men: a cohort study in Paris.

D Denis1, V Seta1, E Regnier-Rosencher1, N Kramkimel1, J Chanal1, M-F Avril1, N Dupin1.   

Abstract

BACKGROUND: Classic Kaposi's sarcoma (CKS) occurs predominantly among elderly men and is associated with Kaposi's sarcoma-associated herpesvirus (KSHV). In low-endemic countries, KSHV infects predominantly men having sex with men (MSM).
OBJECTIVES: To describe a cohort of classic Kaposi sarcoma in a low-endemic area for KSHV, to highlight the features of CKS in MSM and identify prognostic factors.
METHODS: Retrospective single-centre study of CKS cases. We compared MSM to heterosexual patients. Then, we divided the patients into two subgroups, those requiring a systemic treatment and the others, and we performed univariate and multivariate analyses to determine aggressiveness of CKS.
RESULTS: Between 2006 and 2015, seventy-four patients were included. Mean age at diagnosis was 68.9 years; sex ratio (M/F) was 6.4, and 28% were MSM; MSM patients were younger (P = 0.02), less often originated from endemic areas (P < 0.0001). KS was less severe (P = 0.04), required more often a local treatment than a systemic one (P = 0.03). On multivariate analysis, CD4 T-cell count > 500/mm3 at baseline was associated with a reduced risk of severe evolution.
CONCLUSION: First CKS cohort in low-endemic zone. We describe a fifth subtype of KS: KS in MSM. The CD4 T-cell count was found to correlate with prognosis.
© 2018 European Academy of Dermatology and Venereology.

Entities:  

Mesh:

Year:  2018        PMID: 29377280     DOI: 10.1111/jdv.14831

Source DB:  PubMed          Journal:  J Eur Acad Dermatol Venereol        ISSN: 0926-9959            Impact factor:   6.166


  8 in total

1.  [Fast growing, bleeding nodule on the heel].

Authors:  Thomas Kuntz; Antonia Viazis; Bijan Koushk-Jalali; Frank Oellig; Ulrike Wieland; Alexander Kreuter
Journal:  Hautarzt       Date:  2019-11       Impact factor: 0.751

2.  Kaposi Sarcoma of the Medial Foot in an MSM, HIV-Negative Man: A Fifth Clinical Variant.

Authors:  Ritu Swali; Allison Limmer; Stephen K Tyring
Journal:  J Clin Aesthet Dermatol       Date:  2020-10-01

Review 3.  Human Gammaherpesvirus 8 Oncogenes Associated with Kaposi's Sarcoma.

Authors:  Amanda de Oliveira Lopes; Pedro do Nascimento Marinho; Letícia d'Ambrosio de Souza Medeiros; Vanessa Salete de Paula
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

Review 4.  Kaposi Sarcoma, a Trifecta of Pathogenic Mechanisms.

Authors:  Gabriela Rusu-Zota; Oana Mădălina Manole; Cristina Galeș; Elena Porumb-Andrese; Otilia Obadă; Cezar Valentin Mocanu
Journal:  Diagnostics (Basel)       Date:  2022-05-16

Review 5.  Kaposi sarcoma.

Authors:  Ethel Cesarman; Blossom Damania; Susan E Krown; Jeffrey Martin; Mark Bower; Denise Whitby
Journal:  Nat Rev Dis Primers       Date:  2019-01-31       Impact factor: 52.329

Review 6.  Classic KSHV/HHV-8-positive Primary Effusion Lymphoma (PEL): A Systematic Review and Meta-Analysis of Case Reports.

Authors:  Ilaria Cozzi; Giovanni Rossi; Emma Rullo; Valeria Ascoli
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-03-01       Impact factor: 2.576

7.  Molecular Mechanisms of Kaposi Sarcoma Development.

Authors:  Andy Karabajakian; Isabelle Ray-Coquard; Jean-Yves Blay
Journal:  Cancers (Basel)       Date:  2022-04-07       Impact factor: 6.575

8.  An unusual series of patients with Kaposi sarcoma.

Authors:  Jiasen Wang; Holly Reid; Natasha Klimas; Misha Koshelev
Journal:  JAAD Case Rep       Date:  2019-07-31
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.